NursingPlex
    Sign In
    Ati Lpn 112 Med Surg Final Proctored Exam

    A nurse is caring for a client who has paranoid schizophrenia and a new prescription for risperidone. The client asks the nurse what the medicine is supposed to do. Which of the following responses should the nurse make?

    Explanation & Rationale

    Choice A rationale This explanation is incorrect because the primary pharmacological mechanism of risperidone is not targeted toward mood elevation. Risperidone is an atypical antipsychotic that works by antagonizing dopamine D2 and serotonin 5-HT2A receptors. While mood stabilization can occur as a secondary effect in some psychotic disorders, the specific therapeutic intent for a client with paranoid schizophrenia is the management of positive symptoms like hallucinations and delusions rather than treating clinical depression or elevating mood. Choice B rationale This rationale is inaccurate because risperidone is not classified as an anxiolytic. While reducing psychotic symptoms might indirectly lower a client's stress levels, the drug's primary action involves modulating neurotransmitters to reduce the severity of psychosis. Chronic anxiety is typically managed with benzodiazepines or selective serotonin reuptake inhibitors. Using risperidone solely for anxiety would be an off-label use and does not address the core pathology of schizophrenia described in the client's current clinical profile. Choice C rationale Risperidone is an atypical antipsychotic that functions by blocking dopamine D2 receptors and serotonin 5-HT2A receptors in the brain. In paranoid schizophrenia, excessive dopamine activity in the mesolimbic pathway contributes to disorganized thinking, delusions, and hallucinations. By modulating these neurotransmitter levels, the medication helps to organize thought processes, reduce paranoid ideation, and improve cognitive clarity. This allows the client to process information more effectively and diminishes the impact of distressing psychotic symptoms. Choice D rationale This statement is scientifically incorrect because risperidone is not a prophylactic treatment for clinical depression. While it is sometimes used as an adjunctive treatment for major depressive disorder with psychotic features, its role in paranoid schizophrenia is the suppression of dopamine-mediated psychosis. Depression is primarily associated with deficiencies in norepinephrine and serotonin, which are addressed by antidepressants. Telling a client that risperidone prevents depression is a misunderstanding of its neurochemical influence on the central nervous system.

    🔒 Submit your answer to reveal